Octagon Capital Advisors’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,298
| Closed | -$973K | – | 34 |
|
|
2024
Q3 | $973K | Hold |
13,298
| – | – | 0.15% | 36 |
|
|
2024
Q2 | $773K | Buy |
13,298
+1,764
| +15% | +$102K | 0.12% | 43 |
|
|
2024
Q1 | $11.9M | Hold |
11,534
| – | – | 1.43% | 21 |
|
|
2023
Q4 | $9.14M | Sell |
11,534
-2,677
| -19% | -$2.12M | 1.46% | 18 |
|
|
2023
Q3 | $6.75M | Sell |
14,211
-3,552
| -20% | -$1.69M | 1.04% | 18 |
|
|
2023
Q2 | $10.7M | Hold |
17,763
| – | – | 1.48% | 15 |
|
|
2023
Q1 | $12.5M | Hold |
17,763
| – | – | 1.8% | 12 |
|
|
2022
Q4 | $18.2M | Buy |
+17,763
| New | +$18.2M | 2.84% | 10 |
|